Literature DB >> 2901268

Effects of beta-blockade on muscle metabolism during prolonged exercise. A short review.

J Cleroux1, F H Leenen.   

Abstract

Endurance during prolonged exercise decreases more markedly with nonselective than beta 1-selective beta-blockade. Because both types of blockers exert comparable effects on cardiac performance, oxygen supply to the working muscle, and extramuscular substrate mobilization, the difference in exercise capacity is apparently due to other factors. The available information in the literature along with experimental results from our laboratory suggests that inhibition of intramuscular lipolysis only occurs with nonselective beta-blockade and may partly account for this difference. In addition, alterations in potassium fluxes are particularly induced by nonselective beta-blockade and result in more pronounced decreases in the intracellular-extracellular potassium ratio during exercise than caused by placebo or beta 1-selective blockade. In contrast to what was initially proposed, intramuscular glycogenolysis appears not to be affected by either type of beta-blockade, and a decrease is unlikely to be involved in the reduced exercise capacity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901268     DOI: 10.1093/ajh/1.3.290s

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

2.  Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.

Authors:  A Head; S Maxwell; M J Kendall
Journal:  Br J Sports Med       Date:  1997-06       Impact factor: 13.800

3.  Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.

Authors:  A Head; S Maxwell; M J Kendall; C Eagles
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.